A combination recombinant protein and outer membrane vesicle vaccine against serogroup B meningococcal disease
Ee Lyn Su(Royal Children's Hospital), Matthew D. Snape(University of Oxford)
Cited by 38
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
T cell and antibody responses induced by a single dose of ChAdOx1 nCoV-19 (AZD1222) vaccine in a phase 1/2 clinical trial
|Nature Medicine|2020|643
Administration of a probiotic with peanut oral immunotherapy: A randomized trial
|Journal of Allergy and Clinical Immunology|2015|436